Grupo Clinico CATEI Sociedad Civil

Guadalajara, Jalisco 44657

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Psoriasis

Studies at this site

• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early